Posted originally on the conservative tree house on May 13, 2022 | Sundance
Fake News CNN’s Jake Tapper asks White House Chief Medical Advisor Anthony Fauci why the White House is sending out false information, aka ‘disinformation’, about when the COVID vaccines were available. Fauci giggles, laughs and says “I have no idea.” WATCH:
U.S. politics has devolved into a grand pretense of a theatrical performance keeping everyone distracted from the severe damage being inflicted by the political ideologues within the Biden administration.
I guarantee you if someone were just to ask Joe Biden at a presser who his Interior Secretary or EPA Administrator were, he’d have absolutely no idea. Biden is purposefully and completely isolated from the policies being carried out by the people running the administration. Biden has no idea what they are doing. None.
Clueless and disconnected Joe Biden is a shallow, empty and at times explosively angry vessel of nothingness. The entire world can see it.
The Australian government is spending millions on an ad campaign to encourage citizens to take a third COVID vaccine. Their method of marketing is quite surprising and I question who would be enticed to take the vaccine upon watching this ad. The campaign features individuals who received the two jabs — and still fell deathly ill with COVID.
You risked your life to take an experimental vaccine, twice, and STILL contracted the virus. Your symptoms were allegedly life-threatening, so the theory that the vaccine will lessen symptoms is moot here. All of that and people are still willingly taking the third vaccine. Cognitive dissonance is strong here.
Nearly 72% of Southern Australians are triple jabbed, yet the government feels it is worth spending $2 million to target that remaining portion who likely do not want another useless vaccine with known side effects. Governments across the globe were hoping we would all be mindless sheep, politely queuing each season for another immunization. Enough is enough.
By joelshirschhorn medical researcher, analyst at Joel S. Hirschhorn | Telling the truth with good data Published originally on TrialSite News on May. 12, 2022, 9:00 a.m.
A global medical mystery is being aggressively pursued by medical researchers. The core issue is that a relatively small fraction of people despite high exposure to COVID have not gotten ill with COVID infection. Think of health workers in hospitals in contact with many seriously ill COVID patients. Also, members of households that stood out because unlike others in the home who got ill with COVID they did not get infected. The mystery is what explains how highly exposed individuals did not get ill with COVID infection.
There are two main ways of explaining resistance to COVID. One is that some people have strengthened their immune systems by any of a number of actions taken before or during the pandemic. For example, some may have elevated levels of vitamin D in their blood by taking high doses of supplements. The other explanation that appeals to medical researchers is that some people have a genetic makeup that gives them total defense against COVID infection,
TrialSite Staff by Staff at TrialSite | Quality Journalism May. 10, 2022, 9:00 a.m.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.
Vaccine producers such as Pfizer, Moderna, Johnson and Johnson (Janssen), AstraZeneca, and others understand that unless there are continued government mandates effectively priming the pump of demand, those individuals with a preference for COVID-19 immunization have already gone ahead with the procedure.
What’s left is a market for boosters and what could become some sort of annual shot available for targeted populations. Of course, in some markets, young children are still a target for COVID-19 vaccines. Regardless, companies now operate in a quite different environment now, than they did in the period of late 2020 through 2021: a period driven by massive government spending, heavy industry influence on the regulatory process, risk-sharing, and the like to a more traditional competitive marketplace.
The Last Market: Young Children
While the children’s markets in places like America are still relevant, awaiting approval, what’s becoming apparent will be the emphasis on booster shots. In the world’s most lucrative drug market, America, Pfizer, and Moderna will more than likely persist as market leaders vying for the parental demands of children as public health agencies such as the CDC continue to emphasize that the risk-benefit analysis of the COVID-19 vaccine favor by a long-shot vaccination. The point of view is that there are no risk-free choices and that it’s better to be safe than sorry with the very youngest members of society.
To date, the CDC recommends the Pfizer vaccine for both the 5-11 age and 12 to 17 cohort while not recommending Moderna. Under 4 is the last market segment the vaccine makers vie for, and if the FDA authorizes, then Pfizer would own that market. A potential battle emerges over this cohort (aged 4-11) as a growing movement concerned for the safety associated with the vaccines, especially the mRNA-based products, gains momentum to question the mass vaccination on this young population. Critics argue that the original premise for mandates and the like was to control community transmission. Given substantial waning vaccine effectiveness combined with mutating variants, critics suggest the risks of serious infection and death are too low, and the safety issues are higher than the government is letting on.
Demand for Vaccines Wane
But demand for vaccines is flat in much of the world. In America, there is little uptick in vaccination as the “fully vaccinated” defined as receiving the two jabs of either Pfizer-BioNTech, Moderna or one jab from Janssen equals 66.8% of the population while about 30.7% of the population opted for a booster dose.
Meanwhile, TrialSite, on several occasions, has chronicled a global glut of COVID-19 vaccines and therapeutics, especially in places like India, the world’s second-highest populated country. In places like Australia, where the death rate associated with COVID-19 has absolutely skyrocketed despite high immunization rates, the public health agencies and politicians continue to promote booster doses as the answer. TrialSite reported recently that Australian politicians in an election season essentially pretend that times are back to normal despite record numbers of cases, near-record hospitalizations, and double the deaths in the first months of 2022 than all of 2020 and 2021 combined.
Some Possible Explanations
Reuters’ Michael Erman and Manas Mishra write that vaccine producers such as Novavax and CureVac, the German mRNA-vaccine maker in partnership with GlaxoSmithKline, seek to target this booster market. Novavax still awaits FDA authorization despite the fact that much of the developed world, from Europe to Canada and Japan to the WHO, have authorized the use of the Novavax vaccine.
Meanwhile, the outlook for Janssen and AstraZeneca (Oxford) is that bright, report the Reuters journalists. According to Hartaj Singh, an analyst from Oppenheimer & Co., “It becomes a very competitive game with companies battling it out with pricing and for market share, even for vaccines that are considered to be the best, like Pfizer and Moderna.”
Interestingly, Pfizer’s CEO Albert Bourla went on the record in an interview recently that those adults that have opted to receive a COVID-19 vaccine are not likely to start accepting shots now in a recognition that the mega push for vaccine administration has come and gone.
Moderna has pegged the unfolding market as the annual shot market, targeting the following:
Adults 50 and above
People with comorbidities or other risks
High-risk occupations (e.g., healthcare, etc.)
According to the estimates of Stephane Bancel, Moderna’s CEO, this emerging annual shot market totals 1.7 billion, representing 21% of the global population. The mRNA-based vaccines are more expensive and cumbersome to distribute and store, hence a sizeable chunk of that estimated target may opt for other vaccines such as the two recently touted by vaccine insiders at WHO including a plant-based vaccine from Canada and one from China.
More than likely Western Europe and America will represent central markets for sales for Pfizer and Moderna who will move toward more competitive, targeted responsive strategies as large government pre-purchases are probably going to be far less. Moreover, TrialSite suggests what were cozy relationships between industry and government agencies will become less so as the various governments’ responses to the pandemic will be a hot topic, especially in democracies in current election cycles.
Key Question: A flu shot model or something else?
The Reuters writers posed an important question in the recent piece: will the likes of Pfizer and Moderna starting this fall market a tailored, redesigned vaccine targeted relevant variants of concern (e.g., Omicron, BA.2, etc.)?
Both Moderna and Pfizer executives are on the record that they are developing Omicron-targeted vaccines.
This becomes an important topic as even the mainstream media starts to become slightly critical of the pandemic response, including mRNA-based vaccine makers that never modified the vaccine product once. The vaccine authorized and approved in the United States was developed based on the original Wuhan variant of SARS-CoV-2 which didn’t seem to make it in circulation to America nor most of the world.
Revenues Decline (but still unprecedented)
2023 sales numbers, while still staggering as compared to historical precedent in the pharmaceutical industry, are nonetheless, on the decline. Reuters reports $17 billion projected for Pfizer-BioNTech (down nearly half from $34 billion) and $10 billion for Moderna as compared to $23 billion in 2022. Sales will continue to drop because enormous fortunes were generated in the winner-take-all pandemic market.
TrialSite suggests the COVID-19 pandemic response must be seriously evaluated due to levels of bias, political interference, and potentially corruption at an unprecedented level. Should the political conditions change in the United States for example, leading to serious inquiries, the pandemic winners may incur unexpected costs.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response. TrialSite Staff by Staff at TrialSite | Quality Journalism
May. 10, 2022, 9:00 a.m.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.
Vaccine producers such as Pfizer, Moderna, Johnson and Johnson (Janssen), AstraZeneca, and others understand that unless there are continued government mandates effectively priming the pump of demand, those individuals with a preference for COVID-19 immunization have already gone ahead with the procedure.
What’s left is a market for boosters and what could become some sort of annual shot available for targeted populations. Of course, in some markets, young children are still a target for COVID-19 vaccines. Regardless, companies now operate in a quite different environment now, than they did in the period of late 2020 through 2021: a period driven by massive government spending, heavy industry influence on the regulatory process, risk-sharing, and the like to a more traditional competitive marketplace.
The Last Market: Young Children
While the children’s markets in places like America are still relevant, awaiting approval, what’s becoming apparent will be the emphasis on booster shots. In the world’s most lucrative drug market, America, Pfizer, and Moderna will more than likely persist as market leaders vying for the parental demands of children as public health agencies such as the CDC continue to emphasize that the risk-benefit analysis of the COVID-19 vaccine favor by a long-shot vaccination. The point of view is that there are no risk-free choices and that it’s better to be safe than sorry with the very youngest members of society.
To date, the CDC recommends the Pfizer vaccine for both the 5-11 age and 12 to 17 cohort while not recommending Moderna. Under 4 is the last market segment the vaccine makers vie for, and if the FDA authorizes, then Pfizer would own that market. A potential battle emerges over this cohort (aged 4-11) as a growing movement concerned for the safety associated with the vaccines, especially the mRNA-based products, gains momentum to question the mass vaccination on this young population. Critics argue that the original premise for mandates and the like was to control community transmission. Given substantial waning vaccine effectiveness combined with mutating variants, critics suggest the risks of serious infection and death are too low, and the safety issues are higher than the government is letting on.
Demand for Vaccines Wane
But demand for vaccines is flat in much of the world. In America, there is little uptick in vaccination as the “fully vaccinated” defined as receiving the two jabs of either Pfizer-BioNTech, Moderna or one jab from Janssen equals 66.8% of the population while about 30.7% of the population opted for a booster dose.
Meanwhile, TrialSite, on several occasions, has chronicled a global glut of COVID-19 vaccines and therapeutics, especially in places like India, the world’s second-highest populated country. In places like Australia, where the death rate associated with COVID-19 has absolutely skyrocketed despite high immunization rates, the public health agencies and politicians continue to promote booster doses as the answer. TrialSite reported recently that Australian politicians in an election season essentially pretend that times are back to normal despite record numbers of cases, near-record hospitalizations, and double the deaths in the first months of 2022 than all of 2020 and 2021 combined.
Some Possible Explanations
Reuters’ Michael Erman and Manas Mishra write that vaccine producers such as Novavax and CureVac, the German mRNA-vaccine maker in partnership with GlaxoSmithKline, seek to target this booster market. Novavax still awaits FDA authorization despite the fact that much of the developed world, from Europe to Canada and Japan to the WHO, have authorized the use of the Novavax vaccine.
Meanwhile, the outlook for Janssen and AstraZeneca (Oxford) is that bright, report the Reuters journalists. According to Hartaj Singh, an analyst from Oppenheimer & Co., “It becomes a very competitive game with companies battling it out with pricing and for market share, even for vaccines that are considered to be the best, like Pfizer and Moderna.”
Interestingly, Pfizer’s CEO Albert Bourla went on the record in an interview recently that those adults that have opted to receive a COVID-19 vaccine are not likely to start accepting shots now in a recognition that the mega push for vaccine administration has come and gone.
Moderna has pegged the unfolding market as the annual shot market, targeting the following:
Adults 50 and above
People with comorbidities or other risks
High-risk occupations (e.g., healthcare, etc.)
According to the estimates of Stephane Bancel, Moderna’s CEO, this emerging annual shot market totals 1.7 billion, representing 21% of the global population. The mRNA-based vaccines are more expensive and cumbersome to distribute and store, hence a sizeable chunk of that estimated target may opt for other vaccines such as the two recently touted by vaccine insiders at WHO including a plant-based vaccine from Canada and one from China.
More than likely Western Europe and America will represent central markets for sales for Pfizer and Moderna who will move toward more competitive, targeted responsive strategies as large government pre-purchases are probably going to be far less. Moreover, TrialSite suggests what were cozy relationships between industry and government agencies will become less so as the various governments’ responses to the pandemic will be a hot topic, especially in democracies in current election cycles.
Key Question: A flu shot model or something else?
The Reuters writers posed an important question in the recent piece: will the likes of Pfizer and Moderna starting this fall market a tailored, redesigned vaccine targeted relevant variants of concern (e.g., Omicron, BA.2, etc.)?
Both Moderna and Pfizer executives are on the record that they are developing Omicron-targeted vaccines.
This becomes an important topic as even the mainstream media starts to become slightly critical of the pandemic response, including mRNA-based vaccine makers that never modified the vaccine product once. The vaccine authorized and approved in the United States was developed based on the original Wuhan variant of SARS-CoV-2 which didn’t seem to make it in circulation to America nor most of the world.
Revenues Decline (but still unprecedented)
2023 sales numbers, while still staggering as compared to historical precedent in the pharmaceutical industry, are nonetheless, on the decline. Reuters reports $17 billion projected for Pfizer-BioNTech (down nearly half from $34 billion) and $10 billion for Moderna as compared to $23 billion in 2022. Sales will continue to drop because enormous fortunes were generated in the winner-take-all pandemic market.
TrialSite suggests the COVID-19 pandemic response must be seriously evaluated due to levels of bias, political interference, and potentially corruption at an unprecedented level. Should the political conditions change in the United States for example, leading to serious inquiries, the pandemic winners may incur unexpected costs.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.
The FDA has finally admitted what we knew all along – the vaccine is not safe. The FDA said it is limiting the availability of Johnson & Johnson’s COVID-19 vaccine as it does indeed cause blood clots. The agency also noted that the vaccine presents a risk of thrombosis with thrombocytopenia syndrome.
The health agencies are still pushing the vaccines from Moderna and Pfizer. How are they any different? The US government has a long history of punishing Johnson & Johnson for their illegal activities, from asbestos-laced baby powder to cancerogenic sunscreen. Yet, all pharmaceutical manufacturers are exempt from penalty for the COVID-19 vaccine, citing a national emergency.
FDA’s vaccine chief Dr. Peter Marks said that the risk of death is still better than not getting the jab and said Johnson & Johnson’s version may be used as a last resort. Johnson & Johnson was hoping to rake in $3.5 billion this year from the vaccine alone. All of this comes down to money and control. The government and businesses forced mandates with complete disregard for public health. The talking heads gaslit the world for years into believing anyone who questioned the vaccine was a conspiracy theory lunatic, unfit for society.
They have known the truth all along. The Johnson & Johnson vaccine came into question in April 2021. Here is Fauci maintaining that the Johnson & Johnson vaccine was “safe and effective” despite knowing it could be deadly:
The Russians are preparing for three possible scenarios that would result in World War III. The first scenario involves attacking the Russian-controlled Zaporozhskaya Nuclear Power Station. The Russian Defense Ministry said the nuclear site is in critical condition, which could lead to a disaster that will certainly be blamed on Russia. It would be easy for world leaders to enter a faraway war over the pretense of nukes.
In the second scenario, Kirillov stated that the Pentagon may deploy weapons of mass destruction (WMD). Specifically, the WMDs would target a large steel mill in the port of Mariupol. He believes the US would do this “discreetly” and in small quantities to avoid being detected. The last option, which Kirillov said is the least probable, would be deploying WMDs directly on the battlefield.
Spy drones have already been spotted in the Kherson Region, and Russian officials believe the drones may be spraying biological and chemical weapons, which would be a major war crime. Russia maintains it has disposed of all of its chemical weapons over five years ago. Izumi Nakamitsu, the UN’s top disarmament official, claims that Ukraine does not possess biological weapons. A US diplomat testified before the Senate that the Pentagon is working to ensure that “the materials of biological research do not fall into the hands of Russian forces.” Yet, Ukraine and its supporters deny that any chemicals exist.
There are indeed labs in Ukraine that potentially contain bio-warfare weapons, but Zelensky maintains they are conducting “ordinary scientific research” amid an active war. Zelensky appeared on CNN to say “all countries have to be worried” about Russia using nuclear or chemical weapons. It seems more likely that Ukraine and not Russia is in possession of such agents.
Gavin Newsom’s goal to become the most woke governor in America has backfired as all words are now deemed offensive as well as hand gestures. The internet is ablaze with angry voters who want Gavin out of office for his transphobic comment. His crime? He stated that men cannot get pregnant. “If men could get pregnant, this wouldn’t even be a conversation,” the non-inclusive and intolerant governor stated in support of Roe v. Wade. Blaming cis-gendered males is OK and encouraged, but stating that they are unable to carry a child is not.
Newsom carelessly failed to mention the other 71 genders who can also give birth. Schools in the US will begin teaching children all 72 genders and will allow them to choose which ones they like the best. Biden has removed the word “mother” from all government documents in favor of “birthing person.” How will they explain to children that a uterus is necessary to produce life?
The Ministry of Truth will certainly clarify the situation for us. Gavin Newsom said abortion “will be the defining issue of the 2022 election,” which is exactly why the Supreme Court document was leaked. Newsom said he will fight to protect “women” – oh no, there he goes again. If his campaign is built on angering the left, he better tread lightly.
A lot of people have written in to ask if I have been consulted for the Star Trek series or if some have used our forecast to write scripts. I have not consulted on Star Trek. If people are tapping into our computer forecasts for ideas, I cannot confirm nor deny that. I understand that connection to our model and I can say an awful lot of people do tune in to Socrates. Let’s hope their visual forecast of the future is not so dramatic. If it makes people think twice – it is fantastic. My fear is that those pulling the strings connected to the mouths of world leaders just for once stop with this nonsense of a Great Reset and let’s sit down and revise the world economy in a rational manner.
Posted originally in the conservative tree house on May 8, 2022 | sundance
It’s the new cool thing. It’s the latest rage on Insta. All the most virtuous people are doing it. Don’t miss out on your opportunity to support the movement. Travel to Kyiv, Ukraine, snap a few selfies… Social media archives will record history. According to pop culture, the Facebook, Insta, Twitter and YouTube social media campaign to save Kyiv, is bigger than the Berlin wall falling. The CIA, DoS, DHS and Nina Jankowicz have declared it true.
When the conflict in Ukraine first began, the White House announced the victor would be the one who could “tell a better story.” The war in Ukraine would be determined by who was more likeable on social media. From that moment forth, winning the PR battle has been the focus.
Within days of the White House declaring the strategy, Google, DuckDuckGo, Facebook, Instagram and Twitter all announced they would filter and block content that did not support World War Reddit. Anyone who was not supporting Ukraine and “churchill in a T-Shirt” ran the risk of being deplatformed; and so, the strategy has continued through today.
After writing pro-Ukraine poems for Nancy Pelosi to read to congress, now Bono travels to Ukraine. I said on March 1st when Bono shows up, that’s the moment when you know western propaganda over Ukraine will soon apex. Bono’s appearance in any State Dept/CIA construct usually precedes the bombing of the proverbial milk factories and subsequent “babies are casualties of war” narrative. Well, today:
Anyone else notice that Bono is slowly morphing into Robin Williams? I digress…
.
Bono wasn’t the only one who showed up to celebrate World War Reddit in Kyiv today. Justin from Canada was also there…
Trudeau: “The incredible courage captivating the essence of what it means to be Ukraine”...
Zelenskyy: “yeah, yeah… yada, yada,… hurry up Bono’s here and that’s a better photo-op“..
Street artists opposed the war in Ukraine have been painting murals in various parts of the world, including Ukraine, the United States, Poland, Argentine, Czech Republic, Italy, Spain, and Bulgaria since Russia launched a large-scale invasion of Ukraine on February 24.
I have created this site to help people have fun in the kitchen. I write about enjoying life both in and out of my kitchen. Life is short! Make the most of it and enjoy!
This is a library of News Events not reported by the Main Stream Media documenting & connecting the dots on How the Obama Marxist Liberal agenda is destroying America
Centinel2012 